Glucomannan for the Treatment of Abdominal Pain-related Functional Gastrointestinal Disorders in Childhood

Phase 4 Completed 89 enrolled Medical University of Warsaw

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Background: Functional abdominal pain disorders (FAPD) are common in school-aged children; however, there is no reliable treatment. Aim: To determine the efficacy and safety of glucomannan for treating FAPD in children. Trial Setting: Department of Pediatrics, The Medical University of Warsaw. Intervention: Patients will be enrolled in a double-blind, randomized controlled trial in which they will receive either glucomannan (10g) or placebo for 4 weeks.

Timeline

Start: 2010-01
Primary completion: 2012-01
Completion: 2012-01

Publications

Horvath A, Dziechciarz P, Szajewska H. Glucomannan for abdominal pain-related functional gastrointestinal disorders in children: a randomized trial. World J Gastroenterol. 2013 May 28;19(20):3062-8. doi: 10.3748/wjg.v19.i20.3062.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	KONJAC MANNAN	Other / unclassified	5 g	Oral

Indications

No indication recorded.